ArticlebioRxiv : the preprint server for biology2026
A closed-loop cell therapy engineered to autonomously secrete Activin A inhibitor protects from fibrodysplasia ossificans progressiva.
Pratik Koirala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.